ArticleScientific reports2026
Accelerating supercritical pharmaceutical formulation via interpretable data-driven prediction of drug solubility.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug solubility in supercritical carbon dioxide (SC-CO2) plays a pivotal role in the development of particle engineering, drug loading, and solvent-free pharmaceutical formulations. However, experimental solubility determination in supercritical systems remains costly, time-consuming, and compound-specific. In this study, an interpretable data-driven framework is proposed to support pharmaceutical formulation scientists by accurately predicting drug solubility in SC-CO2 while elucidating the governing physicochemical factors. Multiple machine learning regressors, including Extreme Gradient Boosting and Support Vector Regression, were developed and further integrated into an ensemble strategy to enhance robustness and generalizability. Model performance was systematically optimized using bio-inspired metaheuristic algorithms, enabling efficient hyperparameter selection across complex, nonlinear search spaces. Beyond predictive accuracy, model interpretability was emphasized through sensitivity-based and amplitude-based feature analyses, revealing the dominant molecular descriptors and process conditions influencing solubility behavior. The results demonstrate that the proposed framework not only improves solubility prediction accuracy but also provides mechanistic insights relevant to drug selection, formulation feasibility, and supercritical processing design. This work establishes a practical computational tool for accelerating pharmaceutical development pipelines involving supercritical fluid technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.